期刊文献+

晚期乳腺癌术前区域性动脉灌注化疗后微血管密度及微淋巴管密度的变化 被引量:2

Effect of preoperative regional intra-arterial infusion chemo-therapy on MVD and LMVD in advanced breast can-cer
原文传递
导出
摘要 目的探讨术前区域动脉灌注化疗及全身静脉化疗对晚期乳腺癌微血管密度(MVD)、微淋巴管密度(MLVD)的影响。方法将76例晚期乳腺癌患者随机分为2组,术前动脉灌注化疗组35例,术前全身静脉化疗组41例,选其中25例化疗前的乳腺癌患者作对照组。采用免疫组化SP法,用CD34、VEGFR3抗体对3组乳腺癌组织标本进行MVD、MLVD检测。结果术前动脉灌注化疗组的MVD为36.05±13.64,全身静脉化疗组为49.92±12.90,对照组为60.38±13.54,各组间比较(P<0.01);术前动脉灌注化疗组的MLVD为6.62±3.70,全身静脉化疗组为9.96±4.57,对照组为11.30±5.32,动脉灌注化疗组与对照组比较显著下降(P<0.01),与静脉化疗组比较差异有统计学意义(P<0.05),静脉化疗组与对照组比较差异无统计学意义(P>0.05)。结论术前区域性动脉灌注化疗比全身静脉化疗更能有效降低肿瘤组织及其周边组织内MVD和MLVD,从而抑制肿瘤细胞生长,减少肿瘤转移的机会。 Objective To investigate the different effect between preoperative regional intra-arterial infusion chemotherapy and preoperative intra-venous infusion chemotherapy on microvessel density (MVD) and lymphatic microvessel density (LMYD) in advanced breast cancer. Methods Seventy-six breast cancer patients were divided into 2 groups : the preoperative regional intra-arterial infusion Chemotherapy group (PIAC group,35 cases), and the preoperative intra-venous infusion chemotherapy group (PIVC group,41 cases) ; and another 25 breast cancer patients without preoperative chemotherapy were as the control group. Using SP immunostaining method, MVD and LMVD of the samples of breast cancer in the 3 groups were detected with CD34 and VEGFR3. Results MVD was 36.05± 13.64 in the PIAC group, 49.92 ±12.90 in the PIVC group and 11.30± 5.32 in the control group; there was a significant difference in comparison of the 3 groups(P〈0.01). MLVD was 6.62 ±3.70 in the PIAC group, 9.96 ±4.57 in the PIVC group and 11.30 ±5.32 in the control group, it was remarkably decreased in the PIAC group compared with the control group, there was a significant difference between the two groups (P 〈0.01 ), the difference between the PIAC group and the PIVC group was statistically significant (P 〈0.05) ,while the difference between the PIVC group and the control group was not statistically significant (P 〉 0.05). Conclusian PIAC can more effectively reduce MVD and MLVD than PIVC, thus restraining the growth of cancer cells and reducing cancer metastasis.
出处 《中华乳腺病杂志(电子版)》 CAS 2007年第3期24-27,共4页 Chinese Journal of Breast Disease(Electronic Edition)
关键词 乳腺癌 动脉灌注化疗 微血管密度 淋巴管密度 Breast neoplasms Intra-arterial infusion chemotherapy Microvessel density Microlyphtic vessel density
  • 相关文献

参考文献8

二级参考文献25

  • 1彭勇,邹利光,席道友.乳腺癌的介入治疗8例报告[J].第三军医大学学报,1994,16(4):300-303. 被引量:6
  • 2柳金彬.Ⅲ期乳腺癌应用动脉导管灌注的新辅助化疗[J].实用肿瘤学杂志,1995,9(3):53-54. 被引量:13
  • 3陈治 黄宗海.VEGF-B和VEGF-C的研究进展[J].国外医学:生理病理科学与临床分册,1999,19(6):479-481.
  • 4Poltorak Z, Cohen T, Sivan R, et al. VEGF145, a secreted vascular endothelia growth factor isoform that binds to extracellular matrix. J Biol Chem, 1997, 272:7151-7158.
  • 5Ferrara N, Gerber H P, LeCouter J The biology of VEGF and its receptors. Nat Med, 2003, 9(6): 669-676.
  • 6Eichmann A, Corbel C, Jaffredo T, et al. Avian VEGF-C:cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors. Development, 1998, 125:743-752.
  • 7Park J E, Chen H H, Winter J, et al. Placenta growth factor.Potentiation of vascular endothelial growth factor bioactivity,in vitro and in vivo, and high affinity binding to Flt- 1 but not to FIk-1/KDR. JBiol Chem, 1994, 269:25646-25654.
  • 8Gille H, Kowalski J, Yu L L, et al. A repressor sequence in the juxtamembrane domain of FIt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth fator-dependent phosphatidylinositol 3 kinase activation and endothelial cell migration. EMBO J, 2000, 19:4064-4073.
  • 9Fong G H, Zhang L Y, Bryce D M, et al. Increased hemangioblast commitment, not vascular disorganized, is the primary defect in fIt- 1 knock-out mice. Development,1999, 126:3015-3025.
  • 10Hiratsuka S, Minowa O, Kuno J, et al. FIt- 1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA, 1998, 4:9349-0354.

共引文献37

同被引文献13

  • 1曹建忠,罗京伟,徐国镇.红细胞生成素在肿瘤放疗中的研究现状[J].中华放射肿瘤学杂志,2006,15(4):267-269. 被引量:4
  • 2李冬,陈江浩,姚青,杨华,王岭.乳腺癌患者新辅助化疗前后淋巴管密度检测[J].中国癌症杂志,2007,17(10):754-757. 被引量:2
  • 3Goneharuk IV,Vorobjova LI,Lukyanova NY,et al.Vascular endothelial growth factor exression in uterine cervical cancer:corelation with clinicopathologic characteristics and survival[J].Exp Oncol,2009,31(3):179-181.
  • 4Duan L,Ye L,Zhao G,et al.Serum slpeen tyrosine Kinase and vascular endothelial growth factor-c levels predict lymph node metastasis of oesophageal squamous cell carcinoma[J].Eur J Cardiothorac Surg,2013,43(3):58-63.
  • 5Cao Y,E GQ,Wang EF,et al.VEGF exerts an angiogenesis in dependent function in cancer cells to promote their malignant progresision[J].Cancer Res,2012,72(16):3 912-3 918.
  • 6Yashiro M,Shinto O,Nakamura K,et al.Effects of VEGFR-3phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma modle[J].Br J Cancer,2009,101(7):786-791.
  • 7Wigle JT,Harvey N,Detmar M,et al.An essential role for Prox1in the induction of the lymphatic endothelial cell phenotype[J].EMBO J,2002,21:1 505-1 513.
  • 8Acs G,Paragh G,Rakosy Z,et al.The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodel metastasis and poor prognosis in early-stage breast carcinoma[J].Mod Pathol,2012,25(2):163-177.
  • 9McColl BK,Baldwin ME,Roufail S,et al.Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D[J].Exp Med,2003,198:863.
  • 10Stacker SA,Caesar C,Baldwin ME,et al.VEGF-D promotes the metastatic spread of tumor cells via the lymphatics[J].Nat Med,2009,7(2):186-189.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部